How Has the Circulating Tumor Cells Market Evolved Historically and What is its Current Size?
The circulating tumor cells market has seen considerable growth due to a variety of factors.
• In recent years, the market size for circulating tumor cells has seen rapid growth. Its predicted expansion from $11.9 billion in 2024 to $13.37 billion in 2025, with a compound annual growth rate (CAGR) of 12.4%, illustrates this trend. The historic period's growth is largely due to factors such as the increasing occurrences and prevalence of cancer, the clinical usefulness in cancer staging, the emergence of liquid biopsies, the demand from patients for less invasive tests, regulatory backing for liquid biopsies, and an emphasis on detecting cancer early.
What Does Future Hold for The Circulating Tumor Cells Market By 2029?
The Circulating Tumor Cells market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the market size for circulating tumor cells is predicted to experience a substantial increase. It is estimated that by 2029, it will amass a total of $21.68 billion, growing at a compound annual growth rate (CAGR) of 12.8%.
Several factors are expected to fuel this growth over the forecasted period: point-of-care CTC testing, the application of microfluidics, attention to rare cancers, standardizing CTC assays, enlarging the scope of CTC-based clinical trials, as well as economic and emerging market growth. The forecast period will also see the proliferation of new CTC isolation techniques, governmental financial support for CTC research, enhancements in CTC detection technologies, the use of liquid biopsy for cancer monitoring, the integration of single-cell analysis capabilities, and technological advancements catalyzed by artificial intelligence (AI).
What Are The Primary Growth Drivers In The Circulating Tumor Cells Market?
The escalating rate of cancer cases is anticipated to spur the growth of the circulating tumor cells industry. The term 'cancer' denotes a disease characterized by uncontrolled growth and spread of a certain number of body cells. Circulating tumor cells play a pivotal role in diagnosing cancer at an early stage, thereby expediting the escalating rate of cancer cases propels the growth of this market sector. To illustrate, the American Cancer Society Journals, a philanthropic health establishment based in the USA, predicted in January 2023 that approximately 1,958,310 new cancer diagnoses would come to light, leading to an estimated 609,820 fatalities due to cancer in the United States. Consequently, the increasing cases of cancer is bolstering the growth of the circulating tumor cells industry.
What Is The Segmentation Of The Global Circulating Tumor Cells Market?
The circulating tumor cells market covered in this report is segmented –
1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems
2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis
3) By Specimen: Blood, Bone Marrow, Other Body Fluids
4) By Application: Clinical Or Liquid Biopsy, Research
Subsegments:
1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits
2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes
3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems
Pre-Book The Circulating Tumor Cells Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Shaping The Circulating Tumor Cells Market Landscape?
A significant trend gaining traction in the circulating tumor cells market is the introduction of innovative products. To consolidate their dominance, the major market players are concentrating on the development of novel products. For example, Bio-Rad Laboratories, Inc., an American medical laboratory, unveiled the Celselect Slides 2.0 in June 2024. This product is engineered to augment the capture of circulating tumor cells (CTCs) and rare cells, thereby boosting the precision and efficacy of cell analysis in clinical and research fields.
Who Are the Key Players In The Circulating Tumor Cells Market?
Major companies operating in the circulating tumor cells market include:
• Precision Medicine Group LLC
• Bio-Techne Corporation
• BIOCEPT Inc.
• Creativ MicroTech Inc.
• Fluxion Biosciences Inc.
• Ikonisys Inc.
• Qiagen N.V.
• ScreenCell SAS
• STEMCELL Technologies Inc.
• Sysmex Corporation
• Aviva Biosciences Corporation
• LungLife AI Inc.
• Miltenyi Biotec GmbH
• Menarini Silicon Biosystems S.p.A.
• Canopus Bioscience Ltd.
• IVDiagnostics Inc.
• BioFluidica Inc.
• Biolidics Limited
• Rarecells Diagnostics SAS
• LineaRx Inc.
• Thermo Fisher Scientific Inc.
• Greiner Bio-One International GmbH
• Stanford Research Institute International
• Agilent Technologies Inc.
• Resolution Bioscience Inc.
• Cynvenio Biosystems Inc.
• ApoCell Inc.
• Clearbridge BioMedics Pte. Ltd.
• Celsee Inc.
• RareCyte Inc.
• On-chip Biotechnologies Co. Ltd.
What Are The Regional Insights Into The Circulating Tumor Cells Market?
North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
